AVNA INC., a leading global manufacturer of components and subassemblies the medical device market, is pleased to announce the appointment of two accomplished professionals, David Bonvenuto and Aaron Mambrino, to its Board of Directors. These appointments underscore AVNA’s continued commitment to strategic growth, operational excellence, and delivering innovative, life-enhancing solutions to people worldwide.

David Bonvenuto brings over three decades of executive leadership in precision manufacturing across highly regulated industries including medical device, aerospace, and defense. His extensive experience includes leading multi-site operations in the U.S., Mexico, and Costa Rica. His board service includes roles with Stellar Precision, XPER Inc., Oberg Industries, and as Chair of the Audit Committee for TriState Capital. Currently, he serves as Director and Operating Partner at Tecum Capital, focusing on strategic growth within the lower middle market.

Aaron Mambrino is a strategic executive with over 25 years of international experience across the medical, aerospace, automotive, and specialty chemicals sectors. She has held key leadership roles including Chief Financial Officer, Chief Operating Officer, and President of the Americas. Ms. Mambrino led a transformative growth initiative that increased company revenue by 400% and improved net operating profit by 900%. Her global operations leadership has spanned six countries and includes oversight of quality, compliance, supply chain, finance, and technology systems. She is also a committed board member, serving on the Audit and Compensation Committees of Torrington Savings Bank and the Finance Committee of Hartford Healthcare, among others.

“David and Aaron each bring exceptional insight and leadership that align with AVNA’s mission to be the trusted partner of choice in the medical device industry,” said Jason Howey, President and CEO of AVNA. “Their diverse backgrounds and strategic expertise will be invaluable as we continue to expand our capabilities, scale globally, and meet the evolving needs of our customers and the patients they serve.”